Saratoga Research & Investment Management Purchases New Shares in Zoetis Inc. $ZTS

Saratoga Research & Investment Management acquired a new position in Zoetis Inc. (NYSE:ZTS - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 98,597 shares of the company's stock, valued at approximately $15,376,000.Which Pet Stock Should Get Your Tail Wagging in 2024?Several other institutional investors and hedge funds have also recently modified their holdings of the stock. North Dallas Bank & Trust Co. bought a new position in Zoetis in the second quarter worth about $922,000. Forefront Wealth Partners LLC boosted its position in Zoetis by 25.6% during the 2nd quarter. Forefront Wealth Partners LLC now owns 1,580 shares of the company's stock valued at $255,000 after acquiring an additional 322 shares in the last quarter. B. Riley Wealth Advisors Inc. purchased a new position in shares of Zoetis during the 2nd quarter worth approximately $1,183,000. Newbridge Financial Services Group Inc. raised its position in shares of Zoetis by 844.9% in the 2nd quarter. Newbridge Financial Services Group Inc. now owns 926 shares of the company's stock worth $144,000 after acquiring an additional 828 shares in the last quarter. Finally, Advisory Services Network LLC raised its position in shares of Zoetis by 7.0% in the 2nd quarter. Advisory Services Network LLC now owns 26,080 shares of the company's stock worth $3,802,000 after acquiring an additional 1,711 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors. Wall Street Analyst Weigh InSeveral equities research analysts recently weighed in on the company. Morgan Stanley dropped their price target on Zoetis from $211.00 to $175.00 and set an "overweight" rating on the stock in a research report on Monday, November 10th. UBS Group lowered their price objective on Zoetis from $158.00 to $141.00 and set a "neutral" rating for the company in a research report on Wednesday, November 5th. JPMorgan Chase & Co. dropped their target price on shares of Zoetis from $230.00 to $200.00 and set an "overweight" rating on the stock in a report on Wednesday, November 5th. Barclays started coverage on shares of Zoetis in a research note on Monday, December 8th. They issued an "equal weight" rating and a $136.00 price target for the company. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Zoetis in a research report on Wednesday, October 8th. Five analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $164.20.MarketBeat Week in Review – 07/31 - 08/04Check Out Our Latest Report on ZTSZoetis Price PerformanceShares of NYSE:ZTS opened at $118.60 on Friday. The business has a fifty day moving average price of $130.95 and a 200-day moving average price of $146.08. The company has a debt-to-equity ratio of 1.31, a current ratio of 3.64 and a quick ratio of 2.28. The company has a market capitalization of $52.26 billion, a PE ratio of 19.97, a PEG ratio of 2.46 and a beta of 0.97. Zoetis Inc. has a 1-year low of $115.25 and a 1-year high of $181.85. Rising Dividend Make Zoetis a Doggone WinnerZoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.62 by $0.08. Zoetis had a net margin of 28.21% and a return on equity of 57.19%. The company had revenue of $2.40 billion for the quarter, compared to analysts' expectations of $2.42 billion. During the same quarter in the previous year, the business posted $1.58 EPS. Zoetis's revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current fiscal year. Zoetis Increases DividendThe company also recently declared a quarterly dividend, which will be paid on Tuesday, March 3rd. Stockholders of record on Tuesday, January 20th will be issued a dividend of $0.53 per share. The ex-dividend date is Tuesday, January 20th. This is a positive change from Zoetis's previous quarterly dividend of $0.50. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.8%. Zoetis's dividend payout ratio is currently 33.67%. Zoetis Company Profile (Free Report)Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.Featured StoriesFive stocks we like better than ZoetisRetail Stocks Investing, ExplainedDisney's $1 Billion Deal Brings Its Magic to OpenAIRussell 2000 Index, How Investors Use it For Profitable TradingWhy Amazon Could Be a $300 Stock Within WeeksUtilities Stocks Explained – How and Why to Invest in UtilitiesAdobe Gets Post-Earnings Lift: Long-Term Outlook Favors UpsideThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Zoetis Right Now?Before you consider Zoetis, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.While Zoetis currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here